PlainPharmaWatch

CMS Open Payments · Program Year 2024

Escala Medical Inc.

Escala Medical Inc. reported $6,029.53 across General Payments, Research, and Ownership to 52 physicians and teaching hospitals across 52 transactions.

See the rankings → How this is sourced
$6.0K
All-tracks total
52
Transactions
52
Recipients
#1696
of 1,925 companies

Escala Medical Inc. reported $6,029.53 across all CMS Open Payments tracks (General + Research + Ownership) to 52 physicians and teaching hospitals in Program Year 2024 - ranking #1696 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $6,029.53, averaging $115.95 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer escala-medical-inc Escala Medical Inc.

$6.0K · #1696/1,925 · 0.0% industry · PY2024

  • TOT $6.0K
  • RANK #1696
  • SHARE 0.0%
  • TXN 52
  • RCP 52
  • CAT 1
  • GEN $6.0K
  • TOP1 5.5%
  • PY 2024

Volume peers

Nearest volume peer: Dunamis Medical, LLC ($6.0K)

Dynasplint Systems Inc.$6.2KAlliance Medical$6.2KDunamis Medical, LLC$6.0KEscala Medical Inc. (this)$6.0KDentalEZ Alabama, Inc.$5.9K
All-tracks payment totals near Escala Medical Inc. (CMS Open Payments PY2024)

Escala Medical Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Escala Medical Inc.

Escala Medical Inc. ranks #1696 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $6,029.53 across 52 transactions to 52 physicians and teaching hospitals - $115.95 per transaction and $115.95 per recipient on average.

Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $6.0K across 52 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Food and Beverage" leads Escala Medical Inc.'s 1-category general-payment breakdown at $6.0K, 100.0% of the reported total.

How Escala Medical Inc. divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$6.0K
Payment Type Amount Transactions
Food and Beverage $6.0K 52

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,001.61 (16.6%) of $6,029.53 in this company's General Payments records across 49 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Escala Medical Inc.

The five named recipients with the highest reported General Payments from this company

Dr. Michael Vardy$330.57Dr. Michael Douso$167.76Nani Moss$167.76Dr. GREGORY FASANI-FELDBERG$167.76Dr. Bruce Kaufmann$167.76
  1. 1

    Dr. Michael Vardy

    $330.57 across 2 reported transactions

  2. 2

    Dr. Michael Douso

    $167.76 across 1 reported transactions

  3. 3

    Nani Moss

    $167.76 across 1 reported transactions

  4. 4

    Dr. GREGORY FASANI-FELDBERG

    $167.76 across 1 reported transactions

  5. 5

    Dr. Bruce Kaufmann

    $167.76 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Escala Medical Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Escala Medical Inc..

Elucent Medical

HHI 265

AltaThera Pharmaceuticals LLC

HHI 265

Aveo Pharmaceuticals, Inc.

HHI 267

Terumo Medical Corporation

HHI 267

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Escala Medical Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Escala Medical Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.